Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: Longitudinal trajectories and clinical applications

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Ferreira, Daniel ^a   Verhagen, Chloë ^a,b   Hernández Cabrera, Juan Andrés ^c   Cavallin, Lena ^a,d   Guo, Chun Jie ^a,e   Ekman, Urban ^a   Muehlboeck, J Sebastian ^a   Simmons, Andrew ^a,f,g   Barroso, José ^c   Wahlund, Lars Olof ^a   Westman, Eric ^a,f  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g King s College London   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ATROPHY; BRAIN; BRAIN CORTEX; CASE CONTROL STUDY; COGNITION; DISEASE EXACERBATION; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE PROCESSING; MALE; MEMORY; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; BIOMARKERS; BRAIN; CASE-CONTROL STUDIES; CEREBRAL CORTEX; COGNITION; DISEASE PROGRESSION; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; PHENOTYPE;

EID: 85017632082     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46263     Document Type: Article

References (48)

1. Noh, Y., et al. Anatomical heterogeneity of Alzheimer disease: Based on cortical thickness on MRIs. Neurology 83, 1936-1944 (2014).
2. Varol, E., Sotiras, A., Davatzikos, C. HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple maxmargin discriminative analysis framework. Neuroimage pii: S1053-8119(16)00150-6. doi: 10. 1016/j.neuroimage. 2016. 02. 041 (2016).
3. Scheltens, N. M. E., et al. The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis. J. Neurol. Neurosurg. Psychiatry 87, 235-243 (2016).
4. Murray, M. E., et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: A retrospective study. Lancet. Neurol. 10, 785-96 (2011).
5. Peter, J., et al. Subgroups of Alzheimer's disease: Stability of empirical clusters over time. J. Alzheimers. Dis. 42, 651-661 (2014).
6. McKhann, G. M., et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers. Dement. 7, 263-269 (2011).
7. Morris, J. C., et al. Harmonized diagnostic criteria for Alzheimer's disease: Recommendations. J. Intern. Med. 275, 204-213 (2014).
8. Dubois, B., et al. Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol. 9, 1118-1127 (2010).
9. Whitwell, J. L., et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: A case-control study. Lancet. Neurol. 11, 868-877 (2012).
10. Whitwell, J. L., et al. Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis. Neurobiol. Aging 32, 1531-1541 (2011).
11. Byun, M. S., et al. Heterogeneity of regional brain atrophy patterns associated with distinct progression rates in Alzheimer's disease. PLoS One 10, e0142756 (2015).
12. Mueller, S. G., et al. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin. N. Am. 15, 869-877 (2005).
13. Jack, C. R., et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J. Magn. Reson. Imaging 27, 685-991 (2008).
14. Shiino, A., et al. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage 33, 17-26 (2006).
15. Hwang, J., et al. Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns. Alzheimer's Dement. (Amst) 2, 58-67 (2015).
16. Davidson, J. E., et al. An exploration of cognitive subgroups in Alzheimer's disease. J. Int. Neuropsychol. Soc. 16, 233-243 (2010).
17. Stopford, C. L., Snowden, J. S., Thompson, J. C., Neary, D. Variability in cognitive presentation of Alzheimer's disease. Cortex 44, 185-195 (2008).
18. Harper, L., et al. MRI visual rating scales in the diagnosis of dementia: Evaluation in 184 post-mortem confirmed cases. Brain 139, 1211-1225 (2016).
19. Ferreira, D., et al. Practical cut-offs for visual rating scales of medial temporal, frontal, posterior atrophy in Alzheimer's disease and mild cognitive impairment. J. Intern. Med. 278, 277-290 (2015).
20. Ferreira, D., et al. Electroencephalography is a good complement to currently established dementia biomarkers. Dement. Geriatr. Cogn. Disord. 42, 80-92 (2016).
21. van der Flier, W. M., et al. Optimizing patient care and research: The Amsterdam Dementia Cohort. J. Alzheimers. Dis. 41, 313-327 (2014).
22. van de Pol, L. A., Scheltens, P. Medial temporal lobe atrophy scores translated to clinical practice: Editorial comment on 'influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs'. J. Intern. Med. 275, 331-333 (2014).
23. Koedam, E. L., et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur. Radiol. 21, 2618-2625 (2011).
24. Scheltens, P., Pasquier, F., Weerts, J., Barkhof, F., Leys, D. Qualitative assessment of cerebral atrophy on MRI: Inter-A nd intraobserver reproducibility in dementia and normal aging. Eur. Neurol. 37, 95-99 (1997).
25. Ferreira, D., et al. Quantitative validation of a visual rating scale for frontal atrophy: Associations with clinical status, APOE e4, CSF biomarkers and cognition. Eur. Radiol. 26, 2597-2610 (2015).
26. Landis, J., Koch, G. The measurement of observer agreement for categorical data. Biometrics 33, 159-174 (1977).
27. van der Flier, W. M., Pijnenburg, Y. Al, Fox, N. C., Scheltens, P. Early-onset versus late-onset Alzheimer's disease: The case of the missing APOE ? 4 allele. Lancet Neurol. 10, 280-288 (2011).
28. Kovacs, G. G. Clinical stratification of subtypes of Alzheimer's disease. Lancet. Neurol. 11, 839-841 (2012).
29. Rivero-Santana, A., et al. Cerebrospinal fluid biomarkers for the differential diagnosis between Alzheimer's disease and frontotemporal lobar degeneration: Systematic review, HSROC analysis, confounding factors. J. Alzheimer's Dis. 55, 625-644. (2016).
30. Wechsler, D. Wechsler Memory Scale-Third Edition. Technical Manual. (The Psychological Corporation, 1997).
31. Muehlboeck, J.-S., Westman, E., Simmons, A. TheHiveDB image data management and analysis framework. Front. Neuroinform. 7, 49 (2014).
32. Ferreira, D., et al. Cognitive decline is mediated by gray matter changes during middle age. Neurobiol. Aging 35, 1086-1094 (2014).
33. Scheltens, P., et al. Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates. J. Neurol. Neurosurg. Psychiatry 55, 967-972 (1992).
34. Orellana, C., et al. Measuring global brain atrophy with the brain volume/cerebrospinal fluid index: Normative values, cut-offs and clinical associations. Neurodegener. Dis. 16, 77-86 (2016).
35. Ramirez, J., McNeely, A. A., Scott, C. J. M., Masellis, M., Black, S. E. White matter hyperintensity burden in elderly cohort studies. The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, Three-City Study. Alzheimers Dement. 12, 203-210 (2016).
36. Hachinski, V. C., et al. Cerebral blood flow in dementia. Arch Neurol 32, 632-637 (1975).
37. Morris, J. C. The Clinical Dementia Rating (CDR): Current vision and scoring rules Neurology. Neurology 43, 2412-2414 (1993).
38. Folstein, M. F., Folstein, S. E., McHugh, P. R. Mini-mental-state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198 (1975).
39. Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H., Chance, J. M., Filos, S. Measurement of functional activities in older adults in the community. J. Gerontol. 37, 323-329 (1982).
40. Sheikh, J., Yesavage, J. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clin Gerontol 5, 165-173 (1986).
41. Schmidt, M. Rey Auditory Verbal Learning Test: A Handbook. (Western Psychological Services, 1996).
42. Reitan, R. Validity of the trail making test as an indicator of organic brain damage. Percept. Mot. Skills 8, 271-276 (1958).
43. Wechsler, D. Wechsler Adult Intelligence Scale-Administration and Scoring Manual, Third Edition. (The Psychological Corporation, San Antonio, TX., 1997).
44. Kaplan, E., Goodglass, H., Weintraub, S. Boston Naming Test. (Lea & Febiger, 1983).
45. Benton, A., Hamsher, K., Sivan, A. Multilingual Aphasia Examination-Second Edition. (AJA Associates, University of Iowa., 1989).
46. Goodglass, H., Kaplan, E. The Assessment Of Aphasia And Related Disorders. (Lea & Febiger., 1983).
47. Hochberg, Y., Benjamin, Y. More powerful procedures for multiple significance testing. Stat. Med. 9, 811-818 (1990).
48. Ferreira, D., et al. Different reserve proxies confer overlapping and unique endurance to cortical thinning in healthy middle-aged adults. Behav. Brain Res. 311, 375-383 (2016).